1. Home
  2. NWS vs NBIX Comparison

NWS vs NBIX Comparison

Compare NWS & NBIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo News Corporation Class B

NWS

News Corporation Class B

HOLD

Current Price

$34.87

Market Cap

17.9B

ML Signal

HOLD

Logo Neurocrine Biosciences Inc.

NBIX

Neurocrine Biosciences Inc.

HOLD

Current Price

$154.16

Market Cap

15.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NWS
NBIX
Founded
2012
1992
Country
United States
United States
Employees
N/A
N/A
Industry
Newspapers/Magazines
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
17.9B
15.5B
IPO Year
2012
1996

Fundamental Metrics

Financial Performance
Metric
NWS
NBIX
Price
$34.87
$154.16
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
22
Target Price
$38.18
$180.91
AVG Volume (30 Days)
1.0M
1.4M
Earning Date
05-07-2026
05-05-2026
Dividend Yield
0.66%
N/A
EPS Growth
N/A
41.95
EPS
1.03
3.30
Revenue
$9,028,000,000.00
$161,626,000.00
Revenue This Year
$6.06
$24.73
Revenue Next Year
$3.25
$13.14
P/E Ratio
$34.29
$47.25
Revenue Growth
6.81
977.51
52 Week Low
$25.49
$122.14
52 Week High
$35.76
$186.12

Technical Indicators

Market Signals
Indicator
NWS
NBIX
Relative Strength Index (RSI) 67.43 42.55
Support Level $29.48 $152.67
Resistance Level $35.31 $161.29
Average True Range (ATR) 0.76 3.72
MACD 0.14 0.28
Stochastic Oscillator 81.74 41.35

Price Performance

Historical Comparison
NWS
NBIX

About NWS News Corporation Class B

News Corporation is a diversified media and information services conglomerate with significant presence in the US, the UK, and Australia. Key mastheads include The Wall Street Journal, Barron's, New York Post, The Times, The Sun, The Australian, Herald Sun, and The Daily Telegraph. Its 61%-owned REA Group is the dominant property listings platform in Australia. In addition, it owns Harper Collins, one of the largest book publishers in the world, and has a sizable US digital property advertising business, Move. The 65% interest in Foxtel, the Australian pay-TV and streaming provider, was sold in April 2025. The sale to global sports streaming platform, DAZN, was struck at more than 7 times Foxtel's EBITDA.

About NBIX Neurocrine Biosciences Inc.

Neurocrine Biosciences Inc is a biopharmaceutical firm focused on the research, development, and commercialization of treatments for neurological, psychiatric, endocrine, and immunological disorders. Its portfolio includes therapies for conditions such as tardive dyskinesia, chorea associated with Huntington's disease, classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency, and treatments for endometriosis and uterine fibroids. The company also maintains a pipeline of drug candidates in various stages of clinical and preclinical development across its therapeutic areas, including small molecules, peptides, proteins, antibodies, conjugates, and gene therapies. It derives revenue from the sale of its pharmaceutical products.

Share on Social Networks: